MRK: MERCK & CO INC Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 63 hrs, 52 mins

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

MERCK & CO INC

MRK

Stock price

38.45 0.41 1.08%

as of 01:00 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

— — —

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: MRK

MERCK & CO INC Profile

Merck helps those who are hooked on hamburgers. Drugs treating ailments associated with bad eating habits -- high cholesterol, hypertension, and heart failure -- are among Merck's biggest sellers. Its drugs include hypertension fighters Cozaar and Hyzaar and cholesterol combatants Vytorin, Zetia, and Zocor. Merck makes drugs in a broad range of other therapeutic areas as well: Propecia treats male pattern baldness, Singulair treats asthma, and Fosamax fights osteoporosis. In addition to pharmaceuticals, the company makes childhood and adult vaccines for such diseases as measles, mumps, hepatitis, and shingles. In 2006 Merck was awarded FDA approval for its cervical cancer vaccine Gardasil.

Richard T. Clark: CEO

1 Merck Dr.

Whitehouse Station, NJ 08889-0100

http://www.merck.com

Phone: 908-423-1000

Fax: 908-735-1253

Sector: Healthcare Industry: Drugs

2007 Sales	2007 Sales Growth	2007 Net Income	2007 Employees
$24,197,700,000	6.9%	$3,275,400,000	59,800

Key Executives: MRK

Name	Title	Officer Since
Richard T. Clark	CEO	5/4/05
Peter N. Kellogg	CFO	-
J. Chris Scalet	Chief Information Officer	-
Bruce N. Kuhlik	General Counsel	-
Kenneth C. Frazier	Executive VP	-
Willie A. Deese	Executive VP	-
Peter S. Kim	Executive VP	-
Celia A. Colbert	Senior VP	-

View All Key Executives

Adam H. Schechter, August, 2007 - President, Global Pharmaceuticals - global responsibilities for the Company's atherosclerosis/cardiovascular, diabetes/obesity, oncology, specialty/neuroscience, respiratory, bone, arthritis and analgesia franchises as well as commercial responsibility in the United States for the Company's portfolio of prescription medicines; July, 2006 - President, U.S. Human Health - commercial responsibility in the United... View Full Profile

Adam H. Schechter

Peter C. Wendell, Managing Director, Sierra Ventures (technology-oriented venture capital firm) for more than five years; Chairman, Princeton University Investment Co. since 2002. Charter Trustee, Princeton University; Faculty, Stanford University Graduate School of Business.... View Full Profile

Peter C. Wendell

Effective August 14, 2007, the Board of Directors of Merck & Co., Inc. approved the election of Peter N. Kellogg to the office of Executive Vice President and Chief Financial Officer. Mr. Kellogg, who is 51 years old, currently serves as executive vice president and chief financial officer of Biogen Idec Inc. ("Biogen"), a biotechnology company, a position he has held since 2004. In that position, Mr. Kellogg is responsible for Biogen's worldwide... View Full Profile

Peter N. Kellogg

Steven F. Goldstone, 61, founder and managing partner, Silver Spring Group (private investment firm) for more than five years, will join the Company's Board of Directors effective Sept 25, 2007. Mr. Goldstone was retired chairman and chief executive officer of RJR Nabisco, Inc., one of the world's largest consumer products companies, from 1995 until his retirement five years later in 2000. Prior to that role, he was a partner at the New York law... View Full Profile

Steven F. Goldstone

Kenneth C. Frazier, August, 2007 - Executive Vice President and President, Global Human Health - responsible for the Company's marketing and sales organizations worldwide, including the global pharmaceutical and vaccine franchises; November, 2006 - Executive Vice President and General Counsel - responsible for legal and public affairs functions and The Merck Company Foundation (a not-for-profit charitable organization affiliated with the... View Full Profile

Kenneth C. Frazier

Dr. Jacobson, Vice Chancellor, Health Affairs, Vanderbilt University Medical Center for more than five years. Director, CeleNova BioSciences, Inc., HealthGate Data Corporation, Ingram Industries, Inc. and Kinetic Concepts, Inc.; Member, American Society of Clinical Investigation, Association of American Physicians, Society of Medical Administrators, and Institute of Medicine. Dr. Jacobson earned his M.D. degree from the University of Illinois.... View Full Profile

Dr. Harry R. Jacobson, M.D.

Thomas H. Glocer, 48, Chief Executive Officer, Reuters Group PLC (global news and information company) for more than five years, will join the Company's Board of Directors effective Nov 27, 2007. With his election, Mr. Glocer will become one of 11 outside directors on the 12-member board. Mr. Glocer will stand for election by the Company's stockholders in April 2008. Mr. Glocer joined Reuters Group in New York in 1993 and was appointed Chief... View Full Profile

Thomas Henry Glocer

Thomas H. Glocer, 48, Chief Executive Officer, Reuters Group PLC (global news and information company) for more than five years, will join the Company's Board of Directors effective Nov 27, 2007. With his election, Mr. Glocer will become one of 11 outside directors on the 12-member board. Mr. Glocer will stand for election by the Company's stockholders in April 2008. Mr. Glocer joined Reuters Group in New York in 1993 and was appointed Chief... View Full Profile

Judy C. Lewent

Celia A. Colbert, January, 2008 - Senior Vice President, Secretary; January, 1997 - Vice President, Secretary (since September, 1993) and Assistant General Counsel (since November, 1993) Responsible for Corporate Secretary function and Corporate Staff Group.... View Full Profile

Celia A. Colbert

Dr. William N. Kelley, M.D.,Professor of Medicine, Biochemistry and Biophysics, University of Pennsylvania School of Medicine for more than five years. Director, Advanced Bio-Surfaces, Inc., Beckman Coulter, Inc., GenVec, Inc. and Polymedix, Inc.; Fellow, American Academy of Arts and Sciences; Master, American College of Physicians and American College of Rheumatology; Member, American Philosophical Society and Institute of Medicine of the... View Full Profile

Dr. William N. Kelley, M.D.

August, 2006 - Vice President, Public Affairs. Prior to August 2006, Mr. Kelmar led the global public affairs and communications function at Novartis AG since 2002.... View Full Profile

Steven Kelmar

Willie A. Deese, January, 2008 - Executive Vice President and President, Merck Manufacturing Division ("MMD") - responsible for the Company's global manufacturing, procurement, and operational excellence functions; May, 2005 - President, Merck Manufacturing Division - responsible for the Company's global manufacturing, procurement, and operational excellence functions; January, 2004 - Senior Vice President, Global Procurement. Prior to January... View Full Profile

Willie A. Deese

J. Chris Scalet, January, 2008 - Executive Vice President, Global Services, and Chief Information Officer ("CIO") - responsible for Global Shared Services across the human resources, finance, site services and information services function; and the enterprise business process redesign initiative; January, 2006 - Senior Vice President, Global Services, and CIO - responsible for Global Shared Services across the human resources, finance, site... View Full Profile

J. Chris Scalet

Dr. Thomas E. Shenk, Ph.D., Elkins Professor (since 1984) and Chairman (1996-2004), Department of Molecular Biology, Princeton University. Director, Cell Genesys, Inc. and CV Therapeutics, Inc.; Fellow, American Academy of Arts and Sciences; Member, American Academy of Microbiology and National Academy of Sciences and its Institute of Medicine.... View Full Profile

Dr. Thomas E. Shenk, Ph.D.

John Canan, January, 2008 - Senior Vice President and Controller - responsible for the Corporate Controller's Group; September, 2006 - Vice President, Controller- responsible for the Corporate Controller's Group; June, 2003 - Vice President, Corporate Audit & Assurance Services; September, 2002 - Vice President and Controller, Asia and Joint Ventures - responsible for financial and operational oversight of Asia Human Health and several of the... View Full Profile

John Canan

Mark E. Mcdonough, February, 2007 - Vice President and Treasurer - responsible for the Company's treasury function, and for providing financial support for Human Resources; January, 2004 - Assistant Treasurer, Global Capital Markets - responsible for managing the Company's investment and financing portfolios and the treasury share repurchase program; September, 2000 - Senior Director, Human Health Finance - responsible for providing global... View Full Profile

Mark E. Mcdonough

Stefan Oschmann, September, 2006 - President, Europe, Middle East, Africa & Canada; October, 2005 - Senior Vice President, Worldwide Human Health Marketing; January, 2001 - Managing Director, MSD Germany, a subsidiary of the Company.... View Full Profile

Stefan Oschmann

Wendy L. Yarno, August, 2007 - Chief Marketing Officer - responsible for the global human health commercial operations support organization, including the Company's Global Human Health Business Process and Program Management, Global Marketing Support, Global Medical Affairs, Global Product Access and Outcomes Research, and Global Alliance Management and New Product Licensing; September, 2006 - Chief Marketing Officer - responsible for Global... View Full Profile

Wendy L. Yarno

Wendell P. Weeks, Chairman and Chief Executive Officer (since April 2007), President and Chief Executive Officer (April 2005-April 2007), President and Chief Operating Officer (April 2002-April 2005), Corning Incorporated (technology company in the telecommunications, information display and advanced materials industries). Director, Corning Incorporated; Trustee, Lehigh University.... View Full Profile

Wendell P. Weeks

William B. Harrison, Jr., Retired Chairman of the Board (since December 31, 2006), prior to which he was Chairman (from November 2001) and Chief Executive Officer (from November 2001 until December 2005), JPMorgan Chase & Co. (financial services) Director, Cousins Properties Incorporated; Member, The Business Council, The Financial Services Forum, The Financial Services Roundtable and The Institute of International Economics.... View Full Profile

William B. Harrison, Jr.

David W. Anstice, September, 2006 - Executive Vice President, Strategy Initiatives - responsible for the End-to-End and global support function initiatives and for providing strategic direction in key pharmaceutical emerging markets (China and India); August, 2005 - President, Human Health-Asia Pacific - responsible for the Company's prescription drug business in the Asia Pacific region, Japan, Australia, New Zealand and the Company's joint... View Full Profile

David W. Anstice

Dr. Johnnetta B. Cole, Ph.D., President Emerita of Spelman College and Bennett College for Women; President, Bennett College for Women (July 2002 through May 2007); Chairman, The JBC Institute for Global Diversity and Inclusion; Member and Past Chair, Board of Trustees, United Way of America; Member, Council on Foreign Relations and National Council of Negro Women; Fellow, American Academy of Arts and Sciences and American Anthropological... View Full Profile

Dr. Johnnetta B. Cole, Ph.D.

Margaret G. McGlynn, August, 2007 - President, Merck Vaccines and Infectious Diseases - global responsibilities for the vaccines business and infectious diseases franchise including the Company's Sanofi-Pasteur joint venture; August, 2005 - President, Merck Vaccines - global responsibilities for the vaccines business including the Company's Sanofi-Pasteur joint venture; January, 2003 - President, U.S. Human Health - responsible for one of the two... View Full Profile

Margaret G. McGlynn

Peter S. Kim, January, 2008 - Executive Vice President and President, Merck Research Laboratories ("MRL") - responsible for the Company's research and development efforts worldwide; January, 2003 - President, Merck Research Laboratories (MRL). February, 2001 - Executive Vice President, Research and Development, MRL.... View Full Profile

Peter S. Kim

Richard T. Clark, Chairman of the Board (since April 2007), President and Chief Executive Officer (since May 2005), President, Merck Manufacturing Division (June 2003-May 2005) of the Company; Chairman, President (January 2000-December 2002) and Chief Executive Officer (January 2003-June 2003), Medco Health Solutions, Inc., formerly a wholly owned subsidiary of the Company Director, Project HOPE and United Negro College Fund; Chairman, Federal... View Full Profile

Richard T. Clark

Dr. Samuel O. Thier, M.D., Professor of Medicine and Health Care Policy, Emeritus (since 2008), Professor of Medicine and Professor of Health Care Policy (1994-2007), Harvard Medical School. Director, Charles River Laboratories, Inc.; Fellow, American Academy of Arts and Sciences; Master, American College of Physicians; Member, Board of Overseers, Teachers Insurance and Annuity Association of America-College Retirement Equities Fund and Cornell... View Full Profile

Dr. Samuel O. Thier, M.D.

Rochelle B. Lazarus, Chairman and Chief Executive Officer, Ogilvy & Mather Worldwide (advertising and marketing communication company) for more than five years. Director, General Electric, New York Presbyterian Hospital, American Museum of Natural History and World Wildlife Fund; Member, Advertising Education Foundation and Board of Overseers, Columbia Business School.... View Full Profile

Rochelle B. Lazarus

Dr. Mirian M. Graddick-Weir, January, 2008 - Executive Vice President, Human Resources - responsible for the Global Human Resources organization; September, 2006 - Senior Vice President, Human Resources. Prior to September 2006, Dr. Graddick-Weir was Executive Vice President of Human Resources and Employee Communications at AT&T, and has held several other senior Human Resources leadership positions at AT&T for more than 20 years (communications... View Full Profile

Dr. Mirian M. Graddick-Weir

Anne M. Tatlock, Retired; Chairman of the Board (from June 2000 until December 31, 2006) and Chief Executive Officer (from September 1999 until December 31, 2006), Fiduciary Trust Company International (global asset management services). Director, Fortune Brands, Inc. and Franklin Resources, Inc.; Chairman, The Andrew W. Mellon Foundation; Fellow, American Academy of Arts and Sciences; Member, Council on Foreign Relations; Trustee, American... View Full Profile

Anne M. Tatlock

Adele D. Ambrose, December, 2007 - Vice President and Chief Communications Officer - responsible for the Global Communications organization; April, 2005 - On sabbatical; Prior to April 2005, Ms. Ambrose was Executive Vice President, Public Relations & Investor Communications at AT&T Wireless (wireless services provider from September 2001 to April 2005).... View Full Profile

Adele D. Ambrose

Bruce N. Kuhlik, January, 2008 - Executive Vice President and General Counsel - responsible for legal, communications, and public policy functions and The Merck Company Foundation (a not-for-profit charitable organization affiliated with the Company); May, 2005 - Vice President and Associate General Counsel - primary responsibility for the Company's Vioxx litigation defense. Prior to May 2005, Mr. Kuhlik was Senior Vice President and General... View Full Profile

Bruce N. Kuhlik

Top Competitors: MRK

View Detailed Competitors Chart

Insider Trends: MRK
Sentiment for MRK is POSITIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: MRK

Date	Name	Shares	Transaction Type	Market Value
05/23/08	KUHLIK BRUCE N	4,000	Exercise of Stock Options	$0.00
05/05/08	CLARK RICHARD T	22,500	Exercise of Stock Options	$0.00
05/02/08	GLOCER THOMAS H	5,000	Purchase	$196,100.00

View All Insider Activity

Ownership Breakdown : MRK

Large Block Holder Type	Number
Institutions	1,546.00
Mutual Fund	3,354.00
Other Major	21.00

Full Details

Indices : MRK

Symbol	Name	Last Trade	Change
$RUI.X	Russell 1000 Index	690.92	-0.56 -0.08%
$INX	S&P 500 Index	1,262.90	1.38 0.11%
$OEX	S&P 100 Index	578.13	2.76 0.48%
$INDU	Dow Jones Industrial Average Index	11,288.54	73.03 0.65%
—	Fortune 500 Industrial Index	—	——%